Kelly Perez is Omniome’s Chief Operating Officer reporting to CEO Robert Wicke. Kelly joined Omniome in 2017 as the SVP of finance. As the COO, Kelly leads development and scale-up of Instrument and Reagent Manufacturing, Finance, IT, Facilities, and Operations.

Kelly was instrumental in the establishment of the general infrastructure of the company (systems, processes, and corporate structure) and continues to oversee those operations.

Prior to joining Omniome, Kelly spent 8 years at Sequenom in various leadership roles including VP of Finance and VP of Corporate Development during builds of multiple genotyping instruments, including launch of an NGS-based NIPT diagnostics business. Kelly also served as the VP of Finance for Luxtera, Inc. where she was responsible for the Finance, Accounting, HR, and IT functions. Her previous employers include Nvidia Corporation, Applied Micro Circuits, and Altera.

Kelly Perez holds a BA in Economics and Architecture from Yale University.